| | Business Summary | | Osteotech,
Inc.
provides
services
and
products
primarily
focused
in
the
repair
and
healing
of
the
musculoskeletal
system.
These
products
and
services
are
marketed
primarily
to
the
orthopedic,
spinal,
neurological,
oral/maxillofacial,
dental
and
general
surgery
markets
in
the
United
States
and
Europe.
The
Company
is
a
processor
and
developer
of
human
bone
and
bone
connective
tissue,
or
allograft
bone
tissue,
forms.
The
allograft
bone
tissue
the
Company
processes
is
procured
by
independent
tissue
banks
or
other
Tissue
Recovery
Organizations
,
primarily
through
the
donation
of
tissue
from
deceased
human
donors,
and
is
used
for
transplantation.
The
Company
has
two
primary
operating
segments,
the
Grafton
Demineralized
Bone
Matrix
Segment
and
the
Base
Allograft
Bone
Tissue
Segment. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Osteotech,
Inc.
provides
services
and
develops
and
markets
products
to
the
orthopaedic,
neurological,
oral/
maxillofacial,
dental
and
general
surgical
markets
in
the
U.S.
and
Europe.
For
the
six
months
ended
6/30/01,
revenues
fell
4%
to
$37.5
million.
Net
loss
totalled
$2.4
million
vs.
an
income
of
$4.5
million.
Results
reflect
increased
competition
in
the
Grafton(R)
DBM
segment,
a
lower
number
of
donors
processed
by
clients
and
the
absence
of
$500
thousand
in
litigation
income. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Donald Johnston, 76
Chairman | -- | Richard Bauer, 56
CEO,
Director | $344K | Arthur Alfaro, 50
Pres,
COO, Director | 312K | Michael Jeffries, 58
CFO,
Exec. VP, Sec., Director | 242K | James Russell, Ph.D., 50
Exec.
VP and CSO | 207K | | Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/o/oste.gif)